CAS: 879507-25-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | NRC-AN-019 REF: 3D-EKB50725CAS: 879507-25-2 | Min. 95% | To inquire | Thu 08 May 25 |
 | AN-019 REF: TM-T26625CAS: 879507-25-2 | 98.01% | 279.00 €~2,375.00 € | Thu 15 May 25 |
NRC-AN-019
CAS:879507-25-2
NRC-AN-019 is an imatinib-resistant drug that belongs to the class of bcr-abl inhibitors. It has …
Formula:
C25H17F6N5O
Purity:
Min. 95%
Molecular weight:
517.4 g/mol
Ref: 3D-EKB50725
| 10mg | 951.00 € | ||
| 25mg | 1,459.00 € | ||
| 50mg | 2,334.00 € |
Estimated delivery in United States, on Thursday 8 May 2025
AN-019
CAS:879507-25-2
AN-019 (NRC-019) is a Bcr-Abl kinase inhibitor with antitumor activity for the study of chronic …
Formula:
C25H17F6N5O
Purity:
98.01%
Color and Shape:
Solid
Molecular weight:
517.43
Ref: TM-T26625
| 1mg | 279.00 € | ||
| 5mg | 685.00 € | ||
| 10mg | 938.00 € | ||
| 25mg | 1,444.00 € | ||
| 50mg | 1,882.00 € | ||
| 100mg | 2,375.00 € |
Estimated delivery in United States, on Thursday 15 May 2025
